EXAS vs FUNC · rev $2.76B vs P/E 10, rev $17.7M
EXACT Sciences Corporation (EXAS) versus First United Corporation (FUNC) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
First United Corporation (FUNC) is a banks - regional company listed on NASDAQ.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported FUNC revenue for 2024-12-31 was $17.7M. Net income was $20.6M. Revenue was up 6.3% from 2023-12-31 to 2024-12-31. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
EXAS currently screens at market cap $20.03B. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
Not investment advice. Open the EXAS and FUNC stock pages for the full models.
Not investment advice.